Effect of loracarbef on the normal oropharyngeal and intestinal microflora
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 23 (2) , 255-260
- https://doi.org/10.3109/00365549109023409
Abstract
20 healthy volunteers received loracarbef capsules 200 mg b.i.d. for 7 days. Saliva and stool specimens were taken before loracarbef administration and on the 2nd, 5th, and 7th day during the administration period, and again 2, 5 and 9 days after withdrawal of the antibiotic to study the effect of loracarbef on the normal microflora. The concentrations of loracarbef in serum, saliva and faeces were determined by an agar diffusion method. The mean serum peak concentration attained after 1 h was 6.8 mg/l and the saliva concentrations were in the range 0-0.9 mg/l. The loracarbef concentrations in faeces ranged from 0 to 0.9 mg/kg. The changes in the the oropharyngeal microflora were minor and only bacteroides rods were affected. In the intestinal aerobic microflora, the number of enterococci and streptococci slightly increased while staphylococci, micrococci, corynebacteria, bacillus and enterobacteria were not affected. The number of bifidobacteria and eubacteria in the anaerobic microflora decreased while no other bacterial groups were affected. One week after withdrawal of loracarbef, both the oropharyngeal and intestinal microflora had returned to normal. No new colonizing loracarbef resistant microorganisms were observed during the investigation period.Keywords
This publication has 6 references indexed in Scilit:
- Impact of Antimicrobial Agents on Human Intestinal MicrofloraJournal of Chemotherapy, 1990
- Studies on the ecological impact of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Pharmacokinetics of LY163892 in infants and childrenAntimicrobial Agents and Chemotherapy, 1988
- In vitro susceptibilities of common pediatric pathogens to LY163892Antimicrobial Agents and Chemotherapy, 1988
- In vitro activities of LY163892, cefaclor, and cefuroximeAntimicrobial Agents and Chemotherapy, 1988
- Effect of Phenoxymethylpenicillin and Clindamycin on the Oral, Throat and Faecal Microflora of ManScandinavian Journal of Infectious Diseases, 1979